Targeted therapy for canine osteoarthritis


Targeted therapy for canine osteoarthritis seeks a more focused approach compared to using systemic treatments

This content sponsored by Synovetin OA

This segment of dvm360® Live!™ features a clinical discussion with board-certified veterinary rehabilitation specialist Matt Brunke, DVM, DACVSMR, CCRP, CVPP, CVA. Brunke shares the concept of targeted therapy for treatment of canine osteoarthritis, which focuses on targeting the specific joint, rather than using systemic drugs.

Below is a partial transcript. See the video below for more:

Matt Brunke, DVM, DACVSMR, CCRP, CVPP, CVA: Targeted therapy, especially for [osetoarthritis]...because if you only have one arthritic joint, why are we giving systemic meds? While [they are] safe and efficacious, there's a chance that they could have issues. And if your only issue is in 1 elbow, then why not approach that 1 elbow, right?

Because arthritis is an inflammatory disease. It's a puffy joint; it's sore. I will always tell owners that it's, you know, it's like a rusted out hinge like a door. It doesn't bend as well, so it's going to impact their ability to move and stand and do all these things. And that's an uncomfortable thing, right? That stretch of that joint makes the nerve endings hurt [and] makes the inflammatory cascade keep happening. So, if that's the only problem, why are we trying to challenge it from a systemic approach? So, that's where targeted therapy came in.

© 2024 MJH Life Sciences

All rights reserved.